Mirae Asset Global Investments’s Tango Therapeutics TNGX Stock Holding History
Bought
Maintained
Sold
Other funds holding TNGX
CAM
HP
TE
PFSRSONJ
CUAMC
DACS
PR
CG
Mirae Asset Global Investments's TNGX Position: Q2 2026 in Review
Mirae Asset Global Investments reduced its Tango Therapeutics (TNGX) stake by 7.9% in Q2 2026, selling an estimated $13.7K and leaving 6,469 shares worth $202K. The position accounts for ﹤0.01% of the portfolio, ranked #1115.
Mirae Asset Global Investments first reported a position in TNGX in Q2 2022 and has held it in 17 quarters since. The position peaked at $241K in Q3 2023. 24 funds tracked by Wall St. Rank hold TNGX as of Q2 2026.
- Mirae Asset Global Investments held 6,469 shares of Tango Therapeutics worth $202K as of Q2 2026.
- Mirae Asset Global Investments sold 556 Tango Therapeutics shares in Q2 2026, an estimated $13.7K.
- Tango Therapeutics made up ﹤0.01% of Mirae Asset Global Investments's portfolio in Q2 2026, its #1115 holding.
- Mirae Asset Global Investments first reported a position in Tango Therapeutics in Q2 2022 and has held it in 17 quarters since.
- Mirae Asset Global Investments's Tango Therapeutics position peaked at $241K in Q3 2023.
- 24 funds tracked by Wall St. Rank held Tango Therapeutics as of Q2 2026.
Based on Mirae Asset Global Investments's 13F filing for Q2 2026, filed 22 Jul 2026.